BR9712390A - Processo para a cristalização de losartano-potássio. - Google Patents

Processo para a cristalização de losartano-potássio.

Info

Publication number
BR9712390A
BR9712390A BR9712390-0A BR9712390A BR9712390A BR 9712390 A BR9712390 A BR 9712390A BR 9712390 A BR9712390 A BR 9712390A BR 9712390 A BR9712390 A BR 9712390A
Authority
BR
Brazil
Prior art keywords
losartan
potassium
crystallization
angiotensin
hypertension
Prior art date
Application number
BR9712390-0A
Other languages
English (en)
Inventor
Patrick Breen
Erik A Dienemann
Albert D Epstein
Karen A Larson
Michael T Kennedy
Hari Mahadevan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9625804.1A external-priority patent/GB9625804D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of BR9712390A publication Critical patent/BR9712390A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

"PROCESSO PARA A CRISTALIZAçãO DE LOSARTANO-POTáSSIO". Losartano-potássio é um antagonista de angiotensina II útil no tratamento da hipertensão e da insuficiência cardíaca congestiva (I). Esta invenção refere-se ao processo para a cristalização controlada de losartano-potássio utilizando adição de anti-solvente combinada com semeadura maciça com o objetivo de obter morfologia de cristal desejada e propriedades físicas aparentes necessárias para formulação bem sucedida.
BR9712390-0A 1996-10-29 1997-10-24 Processo para a cristalização de losartano-potássio. BR9712390A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2932696P 1996-10-29 1996-10-29
GBGB9625804.1A GB9625804D0 (en) 1996-12-12 1996-12-12 Process for the crystallization of losartan
PCT/US1997/019442 WO1998018787A1 (en) 1996-10-29 1997-10-24 Process for the crystallization of losartan

Publications (1)

Publication Number Publication Date
BR9712390A true BR9712390A (pt) 1999-08-31

Family

ID=26310606

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712390-0A BR9712390A (pt) 1996-10-29 1997-10-24 Processo para a cristalização de losartano-potássio.

Country Status (18)

Country Link
US (1) US5859258A (pt)
EP (1) EP0937068B1 (pt)
JP (1) JP3249827B2 (pt)
CN (1) CN1101393C (pt)
AR (1) AR010256A1 (pt)
AT (1) ATE214388T1 (pt)
AU (1) AU5089898A (pt)
BR (1) BR9712390A (pt)
CZ (1) CZ291672B6 (pt)
DE (1) DE69711068T2 (pt)
DK (1) DK0937068T3 (pt)
EA (1) EA001046B1 (pt)
ES (1) ES2173433T3 (pt)
HR (1) HRP970565B1 (pt)
PT (1) PT937068E (pt)
SK (1) SK282875B6 (pt)
TW (1) TW411338B (pt)
WO (1) WO1998018787A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001226372A (ja) 1999-12-06 2001-08-21 Sumika Fine Chemicals Co Ltd ロサルタンの結晶性または結晶化された酸付加塩およびロサルタンの精製方法
JP2002080354A (ja) * 2000-09-05 2002-03-19 Kao Corp 血圧降下剤組成物
BR0102252B1 (pt) * 2001-04-10 2013-10-22 Sistema de liberação controlada para antagonista do receptor AT1 da angiotensina II, composição farmacêutica e seu uso
SK722003A3 (en) * 2001-05-18 2003-12-02 Aurobindo Pharma Ltd Process for the crystallization of losartan potassium
WO2003033462A2 (en) * 2001-10-15 2003-04-24 The Regents Of The University Of Michigan Systems and methods for the generation of crystalline polymorphs
CA2464561A1 (en) * 2001-10-25 2003-05-01 Depomed, Inc. Methods of treatment using a gastric retained losartan dosage
EP1634880A3 (en) 2002-04-29 2006-04-12 Teva Pharmaceutical Industries Ltd. Processes for preparing losartan and losartan potassium
US20040097568A1 (en) * 2002-07-29 2004-05-20 Dr. Reddy's Laboratories Limited Crystalline form of losartan potassium
ATE369132T1 (de) * 2002-10-17 2007-08-15 Teva Pharma Verfahren zur herstellung von losartan kaliumsalz mit verbesserten fliesseigenschaften
US20060241305A1 (en) * 2002-10-31 2006-10-26 Yatendra Kumar Amorphous form of losartan potassium
SI1589966T1 (sl) * 2003-01-30 2011-06-30 Lek Pharmaceuticals D.D. Postopek čiščenja losartana
WO2004076442A1 (en) * 2003-02-28 2004-09-10 Ranbaxy Laboratories Limited Polymorphs of losartan
US7345071B2 (en) 2003-05-07 2008-03-18 Ipca Laboratories Limited Process for the synthesis of Losartan potassium
ITMI20032472A1 (it) * 2003-12-16 2005-06-17 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procedimento per la preparazione di losartan potassio cristallino
WO2005066158A2 (en) * 2004-01-06 2005-07-21 Ipca Laboratories Limited An improved process for the synthesis of losartan potassium
EP1776095A1 (en) * 2004-06-23 2007-04-25 Solvay Pharmaceuticals GmbH Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and at1-receptor antagonists
US20050288272A1 (en) * 2004-06-23 2005-12-29 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
ITMI20050551A1 (it) * 2005-04-01 2006-10-02 Dipharma Spa Forma cristallina alfa di losartan potassio
WO2008058402A1 (en) 2006-11-17 2008-05-22 Queen's University At Kingston Compounds and methods for treating protein folding disorders
ES2315141B1 (es) * 2006-11-23 2009-12-22 Quimica Sintetica, S.A Procedimiento para la preparacion de cardesartan cilexetilo en forma cristalina.
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US5206374A (en) * 1991-11-18 1993-04-27 E. I. Du Pont De Nemours And Company Process for preparing tetrazolylphenylboronic acid intermediates
US5310928A (en) * 1991-11-18 1994-05-10 E. I. Du Pont De Nemours And Company Process for preparing biphenyltetrazole compounds
US5130439A (en) * 1991-11-18 1992-07-14 Lo Young S Tetrazolylphenylboronic acid intermediates for the synthesis of AII receptor antagonists
JPH08500323A (ja) * 1991-11-18 1996-01-16 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー Ａ▲ｉｉ▼受容体アンタゴニストの合成のためのテトラゾリルフェニルボロン酸中間体
CA2179067A1 (en) * 1993-12-23 1995-06-29 Gordon Creston Campbell, Jr. Polymorphs of losartan and the process for the preparation of form ii of losartan

Also Published As

Publication number Publication date
SK57099A3 (en) 2000-02-14
WO1998018787A1 (en) 1998-05-07
DE69711068D1 (de) 2002-04-18
EP0937068A1 (en) 1999-08-25
EP0937068B1 (en) 2002-03-13
ATE214388T1 (de) 2002-03-15
DE69711068T2 (de) 2002-09-12
DK0937068T3 (da) 2002-05-21
JP2000504343A (ja) 2000-04-11
CZ291672B6 (cs) 2003-04-16
CN1241186A (zh) 2000-01-12
TW411338B (en) 2000-11-11
JP3249827B2 (ja) 2002-01-21
EA199900427A1 (ru) 1999-10-28
PT937068E (pt) 2002-07-31
ES2173433T3 (es) 2002-10-16
US5859258A (en) 1999-01-12
CN1101393C (zh) 2003-02-12
SK282875B6 (sk) 2003-01-09
HRP970565A2 (en) 1998-08-31
EA001046B1 (ru) 2000-08-28
AR010256A1 (es) 2000-06-07
HRP970565B1 (en) 2003-02-28
CZ151599A3 (cs) 1999-10-13
AU5089898A (en) 1998-05-22

Similar Documents

Publication Publication Date Title
BR9712390A (pt) Processo para a cristalização de losartano-potássio.
ES2175087T3 (es) Compuestos triciclicos utiles en el tratamiento de trastornos de proliferacion celular.
NO952229D0 (no) Anvendelse av karbamazepin og okskarbazepin ved behandling av neurologiske lesjoner relatert til traumatiske skader
HUP9603484A2 (hu) Gyógyászati készítmények és eljárás ingerületátvitel befolyásolására
DE69625691T2 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
DE69230242T2 (de) Verfahren zur Reinigung von Hyaluronsäure und Fraktion von reiner Hyaluronsäurezur ophthalmischen Verwendung.
AU651369B2 (en) Method and apparatus for the fixation of bone fractures, limb lengthening and the correction of deformities
AR008853A1 (es) Nuevos compuestos farmaceuticamente activos, su uso en la fabricacion de medicamentos, metodo de tratamiento, composicion farmaceutica, compuestosintermediarios y proceso para la fabricacion de dichos compuestos
CA2220505A1 (en) N,o-carboxymethylchitosan for prevention of surgical adhesions
DK0429570T3 (da) Osteoinducerende præparater
DE69616376T2 (de) Verwendung von Tiagabin zur Behandlung von Schlafstörungen
PT804562E (pt) Factor 2 de crescimento de tecido conjuntivo
NO971789L (no) Di-tert-butylfenolforbindelser med heterocyklisk enhet for anvendelse som antiinflammatoriske midler
MY114428A (en) New pharmacological use of aii-receptor antagonists
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
ES2042530T3 (es) Procedimiento para la preparacion de derivados de acido ursodesoxicolico terapeuticamente activos.
NZ299006A (en) Use of 4-dichlorophenyl tetrahydro N-methyl-1-naphthalenamine (sertraline) for heart attack treatment
ITVR950078A0 (it) Strumentario per il trattamento di fratture articolari della caviglia
Bidwell et al. Leg lengthening for short stature in Turner’s syndrome
DE69530771D1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophenderivaten zur herstellung eines medikaments zur knochen- und bruchheilung
Price et al. Radial lengthening for septic growth arrest
BG103859A (en) The use of 1-ar(alk)yl-imidazolin-2-on for the treatment of fear and stress conditions
SU1115731A1 (ru) Способ лечени послеожогового отека лица
ATE265444T1 (de) D-ring modifizierte gibberellinverbindungen und ihre herstellung und verwendung
ATE225664T1 (de) Verwendung von humanem alpha 1-sauren glycoprotein zur herstellung einer pharmazeutischen präparation

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA (ART.8O COMBINADO COM ART. 13 DA LP).

B12B Appeal against refusal [chapter 12.2 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time